孟鲁司特治疗轻度持续性支气管哮喘疗效观察  

Effect of Montelukast in Treatment of Mild Persistent Bronchial Asthma

作　　者：乔云峰[1] 王冬梅[2] 

机构地区：[1]吉林省人民医院呼吸内科,长春130021 [2]吉林省人民医院心内科,长春130021

出　　处：《中国卫生标准管理》2015年第19期111-112,共2页China Health Standard Management

摘　　要：目的对孟鲁司特治疗轻度持续性支气管哮喘的临床效果进行探讨。方法选择2012年1月~2013年3月间接受治疗的106例轻度持续性支气管哮喘患者的治疗情况进行回顾性分析,并将其分为研究组和对照组,对其治疗效果进行分析。结果与对照组相比,治疗组在显效率和总有效率值占估计值的百分比均提高,而无效率和咳嗽、喘息、胸闷的缓解时间均降低,差异均有统计学意义（P〈0.05）。结论孟鲁司特在治疗支气管哮喘的过程中表现出较好的临床疗效,并且其副作用小。但是在实际治疗过程中,医生要注意结合患者的实际情况,对支气管哮喘患者的治疗药物进行合理的选择。Objective Clinical effect of montelukast in treatment of mild persistent bronchial asthma.Methods To choose from January 2012 to March 2013,106 cases of patients with mild persistent asthma treatment were analyzed retrospectively and divided into study group and control group.The therapeutic effect analyzed.Results Compared with the control group, treatment group in the eficiency and total eficiency value in the estimation of the percentage values,and were increased without eficiency and coughing, wheezing, chest tightness.The remission time were reduced, diferences were statisticaly significant（P〈 0.05）. Conclusion The clinical efect of the treatment of bronchial asthma by the treatment of bronchial asthma is very good,and the side efect is smal.It is worth promoting and using.But in the actual treatment,the doctor should pay attention to the actual situation of patients and give reasonable choice.

关 键 词：孟鲁司特 轻度持续性支气管哮喘 临床效果 

分 类 号：R562.25[医药卫生—呼吸系统]